Erratum: Clonal MET Amplification as a Determinant of Tyrosine Kinase Inhibitor Resistance in Epidermal Growth Factor Receptor–Mutant Non–Small-Cell Lung Cancer ...
CURRENT ISSUE LIST OF ISSUES COLLECTIONS ASCO Guidelines Meeting Abstracts ABOUT About JCO OP Editorial Roster Permissions Reprints Advertising Become a Reviewer Contact Us Submit REVIEWS November 26, ...
A 64-year-old engineer was diagnosed with a cT2cN0M0, Gleason score 8, adenocarcinoma of the prostate. His prostate-specific antigen level was 15 ng/mL. The case was discussed at the hospital tumor ...
Patients with stage III to IV or recurrent, radiographically apparent EC and no previous chemotherapy or disease progression ≥6 months after neo/adjuvant platinum-based chemotherapy were randomly ...
Factors Associated With Default of Treatment and Follow-Up Among Patients With Cancer: A Cross-Sectional Study From a Lower-Middle-Income Country This study reports on the current status of Radiation ...
Tissue inadequacy and operational challenges may limit lung cancer comprehensive biomarker testing. Here, we describe the initial implementation of a tailored tissue molecular journey at Oncoclínicas ...
Validation of an Updated Algorithm to Identify Patients With Incident Non–Small Cell Lung Cancer in Administrative Claims Databases Although the potential transformative effect of electronic health ...
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...
Diversity and Inclusivity Considerations Are Key When Choosing a Global Oncology Conference Location
The World Cancer Congress 2024 (WCC 2024), 1 organized by the Union for International Cancer Control (UICC), is an important event in advancing the global fight against cancer. This year's conference, ...
Uncovering Surgical Dynamics and Trends in Early Breast Cancer Stage at Diagnosis: Key Insights From a Two-Decade Argentine Database Analysis A minimum of three or four clips were inserted into the ...
Erratum: Onvansertib in Combination With Chemotherapy and Bevacizumab in Second-Line Treatment of KRAS-Mutant Metastatic Colorectal Cancer: A Single-Arm, Phase II Trial The results of the interim ...
Embark on an intimate journey with heartfelt narratives, poignant reflections, and thoughtful dialogues, hosted by Dr. Lidia Schapira. The award-winning podcast JCO Cancer Stories: The Art of Oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback